A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population

The induction of long-lived effector CD8(+) T cells is key to the development of efficient cancer vaccines. In this study, we demonstrated that a Toll-like receptor 2 (TLR2) agonist-fused antigen increased antigen presentation via TLR2 signaling and induced effector memory-like CD8(+) T cells agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chiao-Chieh, Liu, Shih-Jen, Chen, Hsin-Wei, Shen, Kuan-Yin, Leng, Chih-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058719/
https://www.ncbi.nlm.nih.gov/pubmed/27127171
http://dx.doi.org/10.18632/oncotarget.9001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058719/
https://www.ncbi.nlm.nih.gov/pubmed/27127171
http://dx.doi.org/10.18632/oncotarget.9001

Ejemplares similares